Martine J Piccart

机构：Université Libre de Bruxelles, Institut Jules Bordet · ORCID：0000-0001-9068-8504

发表论文 1564 篇 · 总被引 113689 次 · h-index 149

代表论文

• ESMO-Magnitude of Clinical Benefit Scale version 2.0 (ESMO-MCBS v2.0) (2025 · Annals of Oncology · 被引 66)
• Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer (2025 · JAMA · 被引 52)
• Extending the duration of endocrine treatment for early breast cancer: patient-level meta-analysis of 12 randomised trials of aromatase inhibitors in 22 031 postmenopausal women already treated with at least 5 years of endocrine therapy (2025 · The Lancet · 被引 38)
• Abstract GS1-09: OlympiA: A phase 3, multicenter, randomized, placebo-controlled trial of adjuvant olaparib after (neo)adjuvant chemotherapy in patients w/ germline BRCA1 & BRCA2 pathogenic variants & highrisk HER2-negative primary breast cancer: (2025 · Clinical Cancer Research · 被引 27)
• Adapting radiation therapy to immunotherapy: Delineation and treatment planning of pre-operative immune-modulating breast iSBRT in 151 patients treated in the randomized phase II Neo-CheckRay trial (2025 · Radiotherapy and Oncology · 被引 8)
• Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens (2025 · JAMA Oncology · 被引 7)